BNTC – benitec biopharma inc. (US:NASDAQ)
Stock Stats
News
Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development for Oc
Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development for Oc
Benitec Biopharma (BNTC) had its "buy" rating reaffirmed by TD Cowen.
Benitec Biopharma (BNTC) had its "buy" rating reaffirmed by HC Wainwright. They now have a $32.00 price target on the stock.
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference [Yahoo! Finance]
Form 10-K/A Benitec Biopharma Inc. For: Jun 30
Form 8-K Benitec Biopharma Inc. For: Feb 12
Form 10-Q Benitec Biopharma Inc. For: Dec 31
Form EFFECT Benitec Biopharma Inc.
Form 424B3 Benitec Biopharma Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.